Asthma Inhalers Market by Type (Dry Powder Inhaler, Metered-Dose Inhaler, Soft Mist Inhaler), Mode of Operation (Digitally Operated, Manually Operated), End-user, Distribution Channel - Global Forecast 2024-2030

Asthma Inhalers Market by Type (Dry Powder Inhaler, Metered-Dose Inhaler, Soft Mist Inhaler), Mode of Operation (Digitally Operated, Manually Operated), End-user, Distribution Channel - Global Forecast 2024-2030


The Asthma Inhalers Market size was estimated at USD 2.16 billion in 2023 and expected to reach USD 2.46 billion in 2024, at a CAGR 14.48% to reach USD 5.57 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Asthma Inhalers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Asthma Inhalers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Asthma Inhalers Market, highlighting leading vendors and their innovative profiles. These include AMIKO Digital Health, Armstrong Pharmaceuticals, Inc., AstraZeneca PLC, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., CHIESI Farmaceutici S.p.A., Cipla Limited, Cohero Health, Inc., GlaxoSmithKline PLC, H&T Presspart, HELTMAN Medikal A.S., Koninklijke Philips N.V., Luckys Pharma, Merck & Co., Inc., Microlife Corporation, Novartis AG, Nutra Respiro, Omron Corporation, OPKO Health, Inc., PARI GmbH, Pulmatrix, Inc., Sunovion Pharmaceuticals Inc. by Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries Ltd., and Ultratech India Ltd..

Market Segmentation & Coverage

This research report categorizes the Asthma Inhalers Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

Dry Powder Inhaler
  • Metered-Dose Inhaler

    Breath-Actuated Pressurized Metered-dose Inhalers
  • Metered-dose Inhaler with a Spacer
  • Standard Pressurized Metered-Dose Inhalers
  • Soft Mist Inhaler
  • Mode of Operation

    Digitally Operated
  • Manually Operated
  • End-user

    Homecare Facilities
  • Hospitals & Clinics
  • Distribution Channel

    Offline
  • Online
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Asthma Inhalers Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Asthma Inhalers Market?
    3. What are the technology trends and regulatory frameworks in the Asthma Inhalers Market?
    4. What is the market share of the leading vendors in the Asthma Inhalers Market?
    5. Which modes and strategic moves are suitable for entering the Asthma Inhalers Market?


    Note: PDF & Excel + Online Access - 1 Year

  • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Asthma Inhalers Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Increasing prevalence of respiratory disorders globally
    5.1.1.2. Rising adoption of digitally approved asthma inhalers
    5.1.1.3. Government initiatives to stop respiratory disorders
    5.1.2. Restraints
    5.1.2.1. High cost of smart asthma inhalers
    5.1.3. Opportunities
    5.1.3.1. Technological advancements and development of novel asthma inhalers
    5.1.3.2. Growing investment and R&D activities for development of asthma inhalers
    5.1.4. Challenges
    5.1.4.1. Certain problems associated with asthma inhalers
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Asthma Inhalers Market, by Type
    6.1. Introduction
    6.2. Dry Powder Inhaler
    6.3. Metered-Dose Inhaler
    6.4.1. Breath-Actuated Pressurized Metered-dose Inhalers
    6.4.2. Metered-dose Inhaler with a Spacer
    6.4.3. Standard Pressurized Metered-Dose Inhalers
    6.4. Soft Mist Inhaler
    7. Asthma Inhalers Market, by Mode of Operation
    7.1. Introduction
    7.2. Digitally Operated
    7.3. Manually Operated
    8. Asthma Inhalers Market, by End-user
    8.1. Introduction
    8.2. Homecare Facilities
    8.3. Hospitals & Clinics
    9. Asthma Inhalers Market, by Distribution Channel
    9.1. Introduction
    9.2. Offline
    9.3. Online
    10. Americas Asthma Inhalers Market
    10.1. Introduction
    10.2. Argentina
    10.3. Brazil
    10.4. Canada
    10.5. Mexico
    10.6. United States
    11. Asia-Pacific Asthma Inhalers Market
    11.1. Introduction
    11.2. Australia
    11.3. China
    11.4. India
    11.5. Indonesia
    11.6. Japan
    11.7. Malaysia
    11.8. Philippines
    11.9. Singapore
    11.10. South Korea
    11.11. Taiwan
    11.12. Thailand
    11.13. Vietnam
    12. Europe, Middle East & Africa Asthma Inhalers Market
    12.1. Introduction
    12.2. Denmark
    12.3. Egypt
    12.4. Finland
    12.5. France
    12.6. Germany
    12.7. Israel
    12.8. Italy
    12.9. Netherlands
    12.10. Nigeria
    12.11. Norway
    12.12. Poland
    12.13. Qatar
    12.14. Russia
    12.15. Saudi Arabia
    12.16. South Africa
    12.17. Spain
    12.18. Sweden
    12.19. Switzerland
    12.20. Turkey
    12.21. United Arab Emirates
    12.22. United Kingdom
    13. Competitive Landscape
    13.1. FPNV Positioning Matrix
    13.2. Market Share Analysis, By Key Player
    13.3. Competitive Scenario Analysis, By Key Player
    14. Competitive Portfolio
    14.1. Key Company Profiles
    14.1.1. AMIKO Digital Health
    14.1.2. Armstrong Pharmaceuticals, Inc.
    14.1.3. AstraZeneca PLC
    14.1.4. Beximco Pharmaceuticals Ltd.
    14.1.5. Boehringer Ingelheim International GmbH
    14.1.6. Cadila Healthcare Ltd.
    14.1.7. CHIESI Farmaceutici S.p.A.
    14.1.8. Cipla Limited
    14.1.9. Cohero Health, Inc.
    14.1.10. GlaxoSmithKline PLC
    14.1.11. H&T Presspart
    14.1.12. HELTMAN Medikal A.S.
    14.1.13. Koninklijke Philips N.V.
    14.1.14. Luckys Pharma
    14.1.15. Merck & Co., Inc.
    14.1.16. Microlife Corporation
    14.1.17. Novartis AG
    14.1.18. Nutra Respiro
    14.1.19. Omron Corporation
    14.1.20. OPKO Health, Inc.
    14.1.21. PARI GmbH
    14.1.22. Pulmatrix, Inc.
    14.1.23. Sunovion Pharmaceuticals Inc. by Sumitomo Dainippon Pharma Co., Ltd.
    14.1.24. Teva Pharmaceutical Industries Ltd.
    14.1.25. Ultratech India Ltd.
    14.2. Key Product Portfolio
    15. Appendix
    15.1. Discussion Guide
    15.2. License & Pricing
    FIGURE 1. ASTHMA INHALERS MARKET RESEARCH PROCESS
    FIGURE 2. ASTHMA INHALERS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ASTHMA INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ASTHMA INHALERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ASTHMA INHALERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ASTHMA INHALERS MARKET DYNAMICS
    FIGURE 7. ASTHMA INHALERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    FIGURE 8. ASTHMA INHALERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ASTHMA INHALERS MARKET SIZE, BY MODE OF OPERATION, 2023 VS 2030 (%)
    FIGURE 10. ASTHMA INHALERS MARKET SIZE, BY MODE OF OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ASTHMA INHALERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    FIGURE 12. ASTHMA INHALERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. ASTHMA INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
    FIGURE 14. ASTHMA INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. AMERICAS ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 16. AMERICAS ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. UNITED STATES ASTHMA INHALERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 18. UNITED STATES ASTHMA INHALERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. ASIA-PACIFIC ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. ASIA-PACIFIC ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ASTHMA INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 23. ASTHMA INHALERS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 24. ASTHMA INHALERS MARKET SHARE, BY KEY PLAYER, 2023

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings